This randomized controlled trial evaluated the use of Viscum album (VaL) extract in patients with locally advanced or metastatic pancreatic cancer. The study demonstrated that VaL therapy significantly improved overall survival (4.8 months for VaL-treated patients vs. 2.7 months for controls, p
